November 24, 2025 — Leads & Copy — Safe Supply Streaming Co Ltd. (CSE: SPLY) (OTCQB: SSPLF) (FSE: QM4) has secured exclusive Canadian distribution rights for Healthy Sprays LLC’s GLP-1 solutions, marking a significant move into the metabolic health sector.
The Licensing Agreement grants Safe Supply exclusive nationwide distribution rights for Healthy Sprays’ innovative product line, which includes THIN (3.0 mg GLP-1 spray), THIN-R (7.2 mg GLP-1 spray), and THIN-ST (5.0 mg tirzepatide spray). These products feature a proprietary sublingual spray delivery technology, designed for enhanced user experience and rapid impact without refrigeration.
Geoff Benic, CEO of Safe Supply, stated that this partnership is a major step in bringing modern healthcare solutions to Canadians, offering a needle-free GLP-1 therapy alternative for consumers seeking convenience and accessibility. Logan Doughty, CEO of Healthy Sprays, expressed confidence in Safe Supply’s healthcare-focused distribution network and operational discipline to scale their GLP-1 platform across Canada.
The Licensing Agreement, effective January 2026, spans an initial five-year term with extension options. It provides Safe Supply with exclusive distribution rights, access to Healthy Sprays’ business model, operating systems, product IP, and rights to future formulations.
Raf Souccar, Chairman of Safe Supply’s Board of Directors, emphasized that offering a safe, modern alternative to injectable therapies will expand access to metabolic health solutions for Canadians. The company anticipates that innovative GLP-1 therapies like THIN will be an important development as alternative GLP-1 solutions move toward mainstream adoption in Canada.
Under the agreement, Safe Supply will pay Healthy Sprays a one-time, non-refundable upfront license fee of $250,000 USD in tranches. Additionally, Safe Supply will remit a royalty on Canadian gross sales and purchase product packaging and delivery technology directly from Healthy Sprays at a fixed cost. The Licensing Agreement also establishes minimum net sales requirements for each contract year.
Safe Supply has announced a proposed non-brokered private placement of units at C$0.05 per Unit, aiming to raise gross proceeds up to C$500,000. Each unit will comprise one common share and one-half of one common share purchase warrant, exercisable for one share at C$0.075 per share for two years from closing.
The company intends to use the net proceeds from the offering to fund the licensing fee, cover expenses related to activities under the Licensing Agreement, and for general corporate and working capital. The company may pay finders’ fees of up to 7% cash and 7% broker’s warrants exercisable for the purchase of one Unit at a price of $0.05 for a period of two years to eligible finders in connection with the Offering.
Closing of the offering is contingent on obtaining all necessary corporate and regulatory approvals, including approval from the Canadian Securities Exchange. All securities issued in connection with the offering will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation in Canada.
Safe Supply Streaming Co Ltd. focuses on advancing innovation in healthcare, wellness, and emerging technologies. Its subsidiaries, Safety Strips Tech Corp. and Drug Lab 118 Ltd., develop proprietary rapid testing technologies for fentanyl and drink-spiking detection.
Media & Investor Contact:
Safe Supply Streaming Co Ltd.
Email: info@safesupply.com
Geoff Benic, Chief Executive Officer
Email: geoff@safesupply.com
Phone: +1 647-880-7314
Source: Safe Supply Streaming Co Ltd.
